Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

• Arvid Edén ,

  * E-mail: arvid.eden@vgregion.se

  Affiliation Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Thomas D. Marcotte,

  Affiliation Department of Psychiatry, University of California San Diego, San Diego, California, United States of America

  ⨯
• Robert K. Heaton,

  Affiliation Department of Psychiatry, University of California San Diego, San Diego, California, United States of America

  ⨯
• Staffan Nilsson,

  Affiliation Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden

  ⨯
• Henrik Zetterberg,

  Affiliations Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Dietmar Fuchs,

  Affiliation Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Donald Franklin,

  Affiliation Department of Psychiatry, University of California San Diego, San Diego, California, United States of America

  ⨯
• Richard W. Price,

  Affiliation Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Igor Grant,

  Affiliation Department of Psychiatry, University of California San Diego, San Diego, California, United States of America

  ⨯
• Scott L. Letendre,

  Affiliation Department of Psychiatry, University of California San Diego, San Diego, California, United States of America

  ⨯
• Magnus Gisslén

  Affiliation Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯